Morgan Stanley Upgrades Gilead Sciences To Overweight, Shares Rise

Analysts at Morgan Stanley upgraded

from undefined to Overweight. Gilead Sciences shares have jumped 24.92% over the past 52 weeks, while the S&P 500 index has gained 13.45% in the same period. Gilead Sciences' shares rose 1.92% to $95.59 in pre-market trading.